上海金畔生物科技有限公司可以定制不同序列多肽，可以访问官网了解更多产品信息。
| 名称 | Gastric Inhibitory Peptide (GIP), human |
| 编码 | [10040-31-1] |
| 别名 | Gastric Inhibitory Peptide (GIP), human |
| 纯度 | 80%，90%，95%，98%，99% |
| 重量 | 1mg,5mg,10mg,50mg,100mg,1g |
| 序列（单字母缩写） | YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ |
| 序列（三字母缩写） | H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH (trifluoroacetate salt) |
| 基本描述 | GIP fragment that presents potent insulinotropic activity in the isolated perfused rat pancreas, but greatly inhibits somatostatinotropic activity in the isolated perfused rat stomach. The site responsible for insulinotropic activity lies between 19 and 30 of GIP. |
| 溶解度 | |
| 分子量 | 4983.6 |
| 化学式 | C226H338N60O66S1 |
| 存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
| 注释 | |
| Documents | ![Gastric Inhibitory Peptide (GIP), human 编码 [10040-31-1]](http://www.saliva.com.cn/wp-content/uploads/2022/10/20221005_633d4cc070b0b.png) |
| Figures | ![Gastric Inhibitory Peptide (GIP), human 编码 [10040-31-1]](http://www.saliva.com.cn/wp-content/uploads/2022/10/20221005_633d4cc0c52d2.jpg) |
| Reference | A. Moody et al., FEBS Letters, 123, 205 (1981) |
| C端 | |
| N端 | |
| 化学桥 |